Development of novel immunotherapy against malignant glioma

恶性胶质瘤新型免疫疗法的开发

• 批准号: 25670613
• 负责人: SAITO RYUTA
• 金额: $ 2.41万
• 依托单位: Tohoku University
• 依托单位国家: 日本
• 项目类别: Grant-in-Aid for Challenging Exploratory Research
• 财政年份: 2013
• 资助国家: 日本
• 起止时间: 2013-04-01 至 2015-03-31
• 项目状态: 已结题
• 来源: https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-25670613/
• 关键词: 腫瘍ワクチン; 脳腫瘍; 免疫治療; 共刺激因子; グリオーマ; サイトカイン; OX40; CD40

项目成果

OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy.

• DOI: 10.1186/s12943-015-0307-3
• 发表时间: 2015-02-15
• 期刊: Molecular cancer
• 影响因子: 37.3
• 作者: Shibahara I;Saito R;Zhang R;Chonan M;Shoji T;Kanamori M;Sonoda Y;Kumabe T;Kanehira M;Kikuchi T;So T;Watanabe T;Takahashi H;Iwabuchi E;Tanaka Y;Shibahara Y;Sasano H;Ishii N;Tominaga T
• 通讯作者: Tominaga T

Convection-enhanced delivery of nimustine hydrochloride for malignant glioma affecting brainstem

对流增强盐酸尼莫司汀治疗影响脑干的恶性胶质瘤

• 发表时间: 2013
• 作者: Ryuta Saito;Yukihiko Sonoda;Teiji Tominaga
• 通讯作者: Teiji Tominaga

Association between molecular alterations and tumor location and MRI characteristics in anaplastic gliomas

• DOI: 10.1007/s10014-014-0211-3
• 发表时间: 2015-04-01
• 期刊: BRAIN TUMOR PATHOLOGY
• 影响因子: 3.3
• 作者: Sonoda, Yukihiko;Shibahara, Ichiyoo;Tominaga, Teiji
• 通讯作者: Tominaga, Teiji

Early response to chemotherapy as an indicator for the management of germinoma-like tumors of the pineal and/or suprasellar regions

对化疗的早期反应作为松果体和/或鞍上区生殖细胞瘤样肿瘤治疗的指标

• DOI: 10.1016/j.jocn.2013.05.014
• 发表时间: 2014
• 期刊: Journal of Clinical Neuroscience
• 影响因子: 2
• 作者: R. Saito;T. Kumabe;Masayuki Kanamori;Y. Sonoda;Mika Watanabe;S. Mugikura;Shoki Takahashi;T. Tominaga
• 通讯作者: T. Tominaga

Convection-enhanced delivery of nimustine hydrochloride for brainstem malignant glioma: current study and development of new device.

对流增强盐酸尼莫司汀治疗脑干恶性胶质瘤：新装置的当前研究和开发。

• 发表时间: 2014
• 作者: Saito R;Kumabe T;Kanamori M;Sonoda Y;Watanabe M;Mugikura S;Takahashi S;Tominaga T;Ryuta Saito
• 通讯作者: Ryuta Saito